
Mark A. Hlatky, MD
Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine) and Stanford Health Policy Fellow
Department of Health Research and Policy
Stanford University
Redwood Bldg, T150A
Stanford, CA 94305-5405
Research Interests
outcomes research, clinical trials, cost-effectiveness
Mark Hlatky is a professor of Health Research and Policy and of medicine (cardiovascular medicine) at Stanford, as well as a CHP/PCOR fellow. His major interests are in outcomes research, evidence-based medicine, and cost-effectiveness analysis. He introduced data collection about economic and quality of life endpoints in several randomized trials, principally trials of therapies for cardiovascular disease.
Hlatky received his MD from the University of Pennsylvania, and, after residency at the University of Arizona, studied as a Robert Wood Johnson Clinical Scholar at the University of California, San Francisco. He trained in cardiology at Duke University Medical Center, and then joined the Duke faculty. He has been at the Stanford University School of Medicine since 1989, where he is currently professor and chair of Health Research and Policy.
Stanford Departments
Health Research and Policy
Publications
The 5 most recent are displayed. More publications »
- Association of coronary CT angiography or stress testing with subsequent utilization and spending among medicare beneficiaries
Shreibati, J.B., Laurence C. Baker, Mark A. Hlatky
JAMA - Journal of the American Medical Association vol. 306, 19 (2011)
Cost Effectiveness of Genetic Eesting in Family Members of Patients with Long QT Syndrome
Marco V. Perez, Narmadan A. Kumarasamy, Douglas K. Owens, Paul J Wang, Mark A. Hlatky
Circulation: Cardiovascular Quality and Outcomes vol. 4 (2010)
- Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy
Lee KK, Cipriano LE, Douglas K. Owens, Go AS, Mark A. Hlatky
Circulation vol. epub (2010) - Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantations
Cynthia A. Yock, Isbill JM, King SB, Mark A. Hlatky
Journal of Invasive Cardiology vol. 22, 1 (2010)
- CABG versus PCI for multivessel coronary artery disease - authors' reply
Mark A. Hlatky, Dena M. Bravata, Kathryn M. McDonald, Douglas K. Owens
The Lancet vol. 373, 9682 (2009)
Events & Presentations
The 5 most recent are displayed. More events & presentations »
- RIP Seminar: Grant Writing - An Overview
January 9, 2013 CHP/PCOR Research in Progress Seminar
Mark A. Hlatky - Grant Writing - An Overview
February 15, 2012 CHP/PCOR Research in Progress Seminar
Mark A. Hlatky - Cost-Effectiveness of Genetic Testing: Case Study of Long-QT-Syndrome
January 26, 2011 CHP/PCOR Research in Progress Seminar
Mark A. Hlatky - Methods in Cardiovascular Outcomes Research
October 7, 2009 CHP/PCOR Research in Progress Seminar
Mark A. Hlatky
Comparative Effectiveness of Angioplasty and Surgery for Treatment of Coronary Artery Disease
September 24, 2008 CHP/PCOR Research in Progress Seminar
Mark A. Hlatky



About CISAC
Mailing List
@StanfordCISAC
Facebook